[TENAGA] QoQ TTM Result on 31-May-2007 [#3]

Announcement Date
13-Jul-2007
Admission Sponsor
-
Sponsor
-
Financial Year
31-Aug-2007
Quarter
31-May-2007 [#3]
Profit Trend
QoQ- 17.7%
YoY- 158.02%
Quarter Report
View:
Show?
TTM Result
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Revenue 24,217,500 23,927,000 23,320,400 22,814,700 21,925,100 21,074,500 20,384,200 12.18%
PBT 4,638,000 5,072,300 4,765,900 5,232,200 4,455,300 3,346,800 2,756,800 41.49%
Tax -806,900 -735,600 -698,300 -558,800 -474,400 -541,800 -595,100 22.52%
NP 3,831,100 4,336,700 4,067,600 4,673,400 3,980,900 2,805,000 2,161,700 46.49%
-
NP to SH 3,838,200 4,329,800 4,061,100 4,629,100 3,932,800 2,777,500 2,126,900 48.27%
-
Tax Rate 17.40% 14.50% 14.65% 10.68% 10.65% 16.19% 21.59% -
Total Cost 20,386,400 19,590,300 19,252,800 18,141,300 17,944,200 18,269,500 18,222,500 7.77%
-
Net Worth 26,168,409 25,558,792 23,982,929 24,173,664 23,086,424 21,341,906 19,153,735 23.14%
Dividend
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Div 1,570,559 1,565,627 1,565,627 1,349,023 917,351 489,031 489,031 117.83%
Div Payout % 40.92% 36.16% 38.55% 29.14% 23.33% 17.61% 22.99% -
Equity
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Net Worth 26,168,409 25,558,792 23,982,929 24,173,664 23,086,424 21,341,906 19,153,735 23.14%
NOSH 4,332,518 4,331,998 4,329,048 4,316,725 4,283,195 4,184,687 4,075,262 4.16%
Ratio Analysis
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
NP Margin 15.82% 18.12% 17.44% 20.48% 18.16% 13.31% 10.60% -
ROE 14.67% 16.94% 16.93% 19.15% 17.04% 13.01% 11.10% -
Per Share
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
RPS 558.97 552.33 538.70 528.52 511.89 503.61 500.19 7.69%
EPS 88.59 99.95 93.81 107.24 91.82 66.37 52.19 42.34%
DPS 36.30 36.30 36.17 31.25 21.42 11.69 12.00 109.30%
NAPS 6.04 5.90 5.54 5.60 5.39 5.10 4.70 18.22%
Adjusted Per Share Value based on latest NOSH - 4,316,725
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
RPS 417.76 412.75 402.29 393.57 378.22 363.55 351.64 12.18%
EPS 66.21 74.69 70.06 79.85 67.84 47.91 36.69 48.27%
DPS 27.09 27.01 27.01 23.27 15.82 8.44 8.44 117.74%
NAPS 4.5142 4.409 4.1372 4.1701 3.9825 3.6816 3.3041 23.14%
Price Multiplier on Financial Quarter End Date
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Date 29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 -
Price 5.79 9.25 9.95 11.70 12.00 11.00 9.15 -
P/RPS 1.04 1.67 1.85 2.21 2.34 2.18 1.83 -31.41%
P/EPS 6.54 9.25 10.61 10.91 13.07 16.57 17.53 -48.20%
EY 15.30 10.81 9.43 9.17 7.65 6.03 5.70 93.25%
DY 6.27 3.92 3.63 2.67 1.78 1.06 1.31 184.27%
P/NAPS 0.96 1.57 1.80 2.09 2.23 2.16 1.95 -37.67%
Price Multiplier on Announcement Date
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Date 14/04/08 15/01/08 25/10/07 13/07/07 16/04/07 25/01/07 12/10/06 -
Price 4.48 6.37 9.45 11.60 12.20 12.20 9.85 -
P/RPS 0.80 1.15 1.75 2.19 2.38 2.42 1.97 -45.19%
P/EPS 5.06 6.37 10.07 10.82 13.29 18.38 18.87 -58.45%
EY 19.77 15.69 9.93 9.24 7.53 5.44 5.30 140.71%
DY 8.10 5.70 3.83 2.69 1.76 0.96 1.22 253.65%
P/NAPS 0.74 1.08 1.71 2.07 2.26 2.39 2.10 -50.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment